Concepedia

Harry Howard

HH

Statistics

Publications

13

Citations

1.5K

H-Index

12

Active since

1982

Affiliations

Pfizer (United States)(Current)

Harry Howard is an author at Pfizer (United States) specializing in pharmacology, neuropharmacology, and medicine.

ORCID

Publications per year

1982–2011

13

Publications

13

4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants

Reinhard Sarges, Harry Howard, Ronald G. Browne et al. · Journal of Medicinal Chemistry · 1990 · 408 citations · Full text

, , +13

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 322 citations

, , +15

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

Anne W. Schmidt, Lorraine A. Lebel, Harry Howard et al. · European Journal of Pharmacology · 2001 · 292 citations

, , +11

Discovery of Two Clinical Histamine H <sub>3</sub> Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 108 citations · Full text

, , +16

3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic Agents

Harry Howard, John Lowe, Thomas Seeger et al. · Journal of Medicinal Chemistry · 1996 · 90 citations · Full text

, , +15

1–5 of 13